These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21907859)

  • 1. Aerosol drug delivery: developments in device design and clinical use.
    Smith J; Tiner R
    Lancet; 2011 Sep; 378(9795):982; author reply 982. PubMed ID: 21907859
    [No Abstract]   [Full Text] [Related]  

  • 2. A new Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations.
    Hein S; Bur M; Schaefer UF; Lehr CM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):132-8. PubMed ID: 20951200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol delivery device selection for spontaneously breathing patients: 2012.
    Ari A; Restrepo RD;
    Respir Care; 2012 Apr; 57(4):613-26. PubMed ID: 22472501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CFC to HFA transition and its impact on pulmonary drug development.
    Leach CL
    Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry powder inhalers are environmentally preferable to metered-dose inhalers.
    Wintemute K; Miller F
    CMAJ; 2020 Jul; 192(29):E846. PubMed ID: 32690561
    [No Abstract]   [Full Text] [Related]  

  • 6. Aerosol drug delivery: developments in device design and clinical use.
    Rottier B; Grasmeijer F; Hagedoorn P; de Boer AH
    Lancet; 2011 Sep; 378(9795):981-2; author reply 982. PubMed ID: 21907858
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary dispersion formulations: the impact of dispersed powder properties on pressurized metered dose inhaler stability.
    O'Donnell KP; Williams RO
    Drug Dev Ind Pharm; 2013 Mar; 39(3):413-24. PubMed ID: 23216244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can we bring high drug doses to the lung?
    Claus S; Weiler C; Schiewe J; Friess W
    Eur J Pharm Biopharm; 2014 Jan; 86(1):1-6. PubMed ID: 24300444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aerosol therapy].
    Wildhaber JH
    Schweiz Med Wochenschr; 1998 Aug; 128(33):1223-8. PubMed ID: 9757487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaler devices for patients with COPD.
    Fink JB; Colice GL; Hodder R
    COPD; 2013 Aug; 10(4):523-35. PubMed ID: 23537191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma medication delivery: mists and myths.
    Rottier BL; Rubin BK
    Paediatr Respir Rev; 2013 Jun; 14(2):112-8; quiz 118, 137-8. PubMed ID: 23522986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing aerosol delivery by pressurized metered-dose inhalers.
    Rubin BK; Fink JB
    Respir Care; 2005 Sep; 50(9):1191-200. PubMed ID: 16122402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaler devices - from theory to practice.
    Sanchis J; Corrigan C; Levy ML; Viejo JL;
    Respir Med; 2013 Apr; 107(4):495-502. PubMed ID: 23290591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Genuair® inhaler: a novel, multidose dry powder inhaler.
    Chrystyn H; Niederlaender C
    Int J Clin Pract; 2012 Mar; 66(3):309-17. PubMed ID: 22340451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Montreal Protocol: getting over the finishing line?
    Woodcock A
    Lancet; 2009 Feb; 373(9665):705-6. PubMed ID: 19249618
    [No Abstract]   [Full Text] [Related]  

  • 17. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
    Laube BL
    Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propellant gases in metered dose inhalers: their impact on the global environment.
    Balmes JR
    Respir Care; 1991 Sep; 36(9):1037-44. PubMed ID: 10145537
    [No Abstract]   [Full Text] [Related]  

  • 19. [Asthma inhaler with feedback system provided better care and lower costs].
    Ahlbeck L
    Lakartidningen; 2014 Jan 29-Feb 4; 111(5):160. PubMed ID: 24624769
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhaled respiratory medications and the use of chlorofluorocarbons (CFCs). Thoracic Society of Australia and New Zealand.
    Pierce RJ; Seale JP; Ruffin RE
    Med J Aust; 1991 May; 154(10):701-4. PubMed ID: 2034155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.